Market revenue in 2024 | USD 157.2 million |
Market revenue in 2030 | USD 214.2 million |
Growth rate | 5.3% (CAGR from 2025 to 2030) |
Largest segment | Reagents product |
Fastest growing segment | Others Product |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Instruments Product, Reagents Product, Others Product |
Key market players worldwide | Abbott Laboratories, Danaher Corp, BioMerieux SA, Roche Holding AG ADR, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Becton Dickinson & Co, Hologic Inc, Illumina Inc, Grifols SA Ordinary Shares - Class A, Qiagen NV, Siemens Healthineers AG ADR, Sysmex Corp |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to infectious disease molecular diagnostics market will help companies and investors design strategic landscapes.
Reagents product was the largest segment with a revenue share of 67.75% in 2024. Horizon Databook has segmented the Australia infectious disease molecular diagnostics market based on instruments product, reagents product, others product covering the revenue growth of each sub-segment from 2018 to 2030.
Increasing prevalence of sexually transmissible infections and diseases caused by blood-borne viruses is one of the major factors driving market growth in Australia. Moreover, increasing geriatric population is likely to drive growth in Australia.
According to the Australian Institute of Health and Welfare, in 2017, about 1 in 7 people in the country was aged 65 years or above, leading to an increase in disease burden. The rising target population, consumer awareness, and technological advancements is expected to drive the market in the near future.
In addition, various strategic initiatives by local market players, such as launch of new products, are expected to boost the market. For instance, COVID-19 diagnostics research is driven by funding from sources like Medical Research Future Fund.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia infectious disease molecular diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Australia infectious disease molecular diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account